Literature DB >> 5572595

Serum ribonuclease in multiple myeloma.

K Fink, W S Adams, W A Skoog.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5572595     DOI： 10.1016/0002-9343(71)90334-2

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  7 in total

1.  Serum ribonuclease activity in the diagnosis of pancreatic disease.

Authors:  T P Kemmer; P Malfertheiner; M Büchler; M L Kemmer; H Ditschuneit
Journal:  Int J Pancreatol       Date:  1991-01

2.  Secretion of ribonucleases by normal and immortalized cells grown in serum-free culture conditions.

Authors:  M Moenner; E Hatzi; J Badet
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997 Jul-Aug       Impact factor: 2.416

3.  Genetic polymorphism of human serum ribonuclease I (RNase I).

Authors:  T Yasuda; W Sato; K Mizuta; K Kishi
Journal:  Am J Hum Genet       Date:  1988-04       Impact factor: 11.025

4.  Serum RNase in the diagnosis of pancreatic carcinoma.

Authors:  L M Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

5.  Increasing human serum ribonuclease activity is a concomitant phenomenon of ovarian carcinoma.

Authors:  H G Schleich; W Wiest
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

6.  Assessment of the clinical usefulness of serum ribonuclease assays: an indicator for the detection of pancreatic cancer.

Authors:  H Nakane; M Yoshida; T Murakami
Journal:  Gastroenterol Jpn       Date:  1979

7.  Time-dependent changes of plasma ribonuclease activity in female Wistar rats under combination therapy of ovarian carcinoma.

Authors:  A Wolf; H Vahrson; M Hoss
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.